Principal Financial Group Inc Soma Logic, Inc. Transaction History

Principal Financial Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$1.76 - $2.83 $11,441 - $18,397	-6,501 Reduced 11.69%	49,103 $124,000
Q3 2023 Nov 02, 2023	BUY	$1.99 - $2.45 $18,797 - $23,142	9,446 Added 20.46%	55,604 $132,000
Q2 2023 Aug 07, 2023	SELL	$2.1 - $3.36 $989 - $1,582	-471 Reduced 1.01%	46,158 $106,000
Q1 2023 May 09, 2023	BUY	$2.13 - $3.6 $9,195 - $15,541	4,317 Added 10.2%	46,629 $118,000
Q4 2022 Feb 09, 2023	BUY	$2.05 - $3.47 $10,305 - $17,443	5,027 Added 13.48%	42,312 $106,000
Q3 2022 Nov 09, 2022	BUY	$0.63 - $5.47 $4,590 - $39,854	7,286 Added 24.29%	37,285 $108,000
Q2 2022 Aug 10, 2022	BUY	$4.27 - $8.26 $128,095 - $247,791	29,999 New	29,999 $136,000

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.